openPR Logo
Press release

Male Hypogonadism Market Growth Bar Increases $3,233 Million In 2022

01-13-2018 10:44 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: Research Beam Market

Male Hypogonadism Market Growth Bar Increases $3,233 Million

Male hypogonadism is a medical condition characterized by the inability of the testes to produce sufficient amount of testosterone, which is responsible for the development of secondary sexual characteristics. This results in underdevelopment of muscles, impaired growth of body hair, development of breast tissues, and lack of deepening of the voice.

For More Info, Get Sample : http://bit.ly/2Day9tu

The global male hypogonadism market was valued at $2,594 million in 2015, and is estimated to reach $3,233 million by 2022, growing at a CAGR of 3.1% during the analysis period. Globally, the prevalence for hypogonadism among men is on a rise at a rapid rate, and according to multiple studies, only 10–15% of patients receive treatment for this condition. Major factors that drive the market growth include high incidence of hypogonadism; rise in geriatric population; growth in awareness of hypogonadism & its treatment options; and increased risk of developing hypogonadism due to increased incidence of chronic lifestyle diseases such as diabetes and obesity. In March 2015, FDA issued cautions & warnings against use of testosterone products as a therapy, and ordered the manufacturers to change labels & add cautions on their packaging. From recent studies conducted by the FDA, there is a high risk of acquiring cardiovascular diseases due to the use of TRT, thus impeding the market growth during the forecast period. However, novel treatment options that are under developmental stage have shown positive results in terms of efficacy, and they are expected to have lesser or no side effects. Therefore, these advancements are anticipated to provide new opportunities in the future.

The global male hypogonadism market is segmented based on therapy, drug delivery, type, and geography. Based on therapy, it is bifurcated into testosterone replacement therapy (TRT), and gonadotropin and gonadotropin-releasing hormones therapy. Gonadotropin and gonadotropin-releasing hormones therapy is further sub-classified into LH, FSH, human chorionic gonadotropin (hCG), and GnRH. Based on drug delivery, it is classified into topical gels, injectables, transdermal patches, and others. Based on type, it is categorized into Klinefelter's syndrome, Kallmann syndrome, pituitary disorders, and others. Based on geography, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, and rest of Europe), Asia-Pacific (China, Japan, India, and rest of Asia-Pacific), and LAMEA (Latin America, Middle East, and Africa).

MALE HYPOGONADISM MARKET KEY BENEFITS FOR STAKEHOLDERS

• The study provides an in-depth analysis of the market, with current trends and future estimations to elucidate the imminent investment pockets.
• It presents a quantitative analysis from 2014 to 2022, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
• Extensive analysis by therapy helps in understanding the various types of therapies used for the treatment of hypogonadism.
• Comprehensive analysis of geographical regions is provided, which helps in determining the prevailing opportunities in these geographies.
• Key players within the market are profiled and their strategies are analyzed thoroughly to determine competitive outlook of the global market.

MALE HYPOGONADISM MARKET KEY MARKET SEGMENTS

Enquire About Report : http://bit.ly/2r0o2Sf

BY THERAPY

• Testosterone Replacement Therapy
• Gonadotropin and Gonadotropin-Releasing Hormones Therapy
• Luteinizing Hormone (LH)
• Follicle-Stimulating Hormone (FSH)
• Human Chorionic Gonadotropin (hCG)
• Gonadotropin-Releasing Hormone (GnRH)

BY DRUG DELIVERY

• Topical Gels
• Injectables
• Transdermal Patches
• Others

BY TYPE

• Klinefelter's Syndrome
• Kallmann Syndrome
• Pituitary Disorders
• Others

BY GEOGRAPHY

• North America
• U.S.
• Canada
• Mexico
• Europe
• Germany
• UK
• France
• Rest of Europe
• Asia-Pacific
• Japan
• India
• China
• Rest of Asia-Pacific
• LAMEA
• Latin America
• Middle East
• Africa

Also Request For Discount : http://bit.ly/2FzFh02

LIST OF KEY PLAYERS PROFILED IN THE REPORT

• AbbVie Inc.
• Allergan plc
• Astrazeneca plc
• Bayer AG.
• Eli Lilly and Company Ltd.
• Endo International plc.
• Merck & Co., Inc.
• Ferring
• Finox Biotech
• IBSA Institut Biochimque SA
• Laboratoires Genevrier
• Teva Pharmaceutical Industries Ltd.

LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request.)

• Lipocine Inc.
• Pfizer Inc.
• Aytu Biosciences
• Diurnal Group PLC
• Hyundai Pharmaceuticals Co Ltd.
• Perrigo Company plc
• Novus Biologicals, LLC

Table Of Content

• Chapter: 1 INTRODUCTION
• Chapter: 2 EXECUTIVE SUMMARY
• Chapter: 3 MARKET OVERVIEW
• Chapter: 4 MALE HYPOGONADISM MARKET, BY THERAPY
• Chapter: 5 MALE HYPOGONADISM MARKET, BY DRUG DELIVERY
• Chapter: 6 MALE HYPOGONADISM MARKET, BY TYPE
• Chapter: 7 MALE HYPOGONADISM MARKET, BY GEOGRAPHY
• Chapter: 8 COMPANY PROFILES

About Us
We have a large database of quality and precise market research reports that will be very beneficial for your organization. Reports that we sell our authentic in nature and from reputed publishers, hence it can definitely help you with your growth opportunities. Research Beam will always make sure to bring most ethical and high quality reports. We value your relationship with us and look forward for a long term relation.

Contact Us
Global Head Quarters
5933 NE Win Sivers Drive,
#205, Portland, OR 97220
United States
+1 (800) 910-6452
help@researchbeam.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Male Hypogonadism Market Growth Bar Increases $3,233 Million In 2022 here

News-ID: 898680 • Views:

More Releases from Research Beam Market

Blood Plasma Derivatives Market Growing With $44,333 Million At A CAGR of 9.3% From 2017 To 2023.
Blood Plasma Derivatives Market Growing With $44,333 Million At A CAGR of 9.3% F …
Blood plasma is liquid component of blood where the blood cells are suspended. It contains dissolved proteins (albumins, globulins, and fibrinogen), clotting factors, hormones, and electrolytes. Plasma maintains the blood pressure and helps in exchange of important minerals such as sodium and potassium to maintain the pH balance in the body. Plasma derivatives are products that are manufactured from human plasma by plasma fractionation techniques. These derivatives include albumin, factor
Holter ECG Monitoring Market Growing $418.3 Million By 2023
Holter ECG Monitoring Market Growing $418.3 Million By 2023
Holter monitors are devices that allow prolonged monitoring of heart rhythm from a few days to several months, enabling the detection of infrequent arrhythmias in patients. In addition, holter monitors help identify ventricular tachycardia (VT) in patients with recognized risk of sudden cardiac death. Portability of holter monitors significantly propel the market growth as they can be easily worn by the patients to record heart activity for a certain period
Intermittent Catheters Market Reach $2,950.7 Million By 2023
Intermittent Catheters Market Reach $2,950.7 Million By 2023
The global intermittent catheters market was valued at $1,655.5 million in 2016, and is expected to reach $2,950.7 million by 2023 with a CAGR of 8.7% during the forecast period. Intermittent catheter is a disposable medical device, which is used to drain the urinary bladder when an individual is unable to do it naturally. Intermittent catheter consists of a drainage bag that assists to capture the urine. These catheters are
Continuous Glucose Monitoring Systems Market Registering A CAGR Of 22.9% By 2024
Continuous Glucose Monitoring Systems Market Registering A CAGR Of 22.9% By 2024
Continuous glucose monitoring (CGM) is one of the latest technological advancements in the field of diabetes management. CGM system is a type of glucose monitoring device that functions by inserting a biosensor through transcutaneous or subcutaneous route. The embedded sensor measures the glucose levels in interstitial fluid or blood, and transmits the information using a transmitter to a receiver/monitor for displaying the results. These systems play an integral role in

All 5 Releases


More Releases for Chapter:

SISA’s Dharshan Shanthamurthy Addresses ISACA Bangalore Chapter
Bengaluru May 1, 2019: SISA Information Security, a global payment security specialist, announced that Mr. Dharshan Shanthamurthy, Founder and CEO, SISA Information Security recently delivered an informative address on payment security to the ISACA Bangalore Chapter on Saturday 27th April 2019. Mr. Shanthamurthy drew from his own first hand observations of the payment industry, garnered over the years. He spoke about emerging trends in the payments industry, including some of
Chapter 4 of 'Meri Pyaari Bindu'
While the first three chapters of Ayushmann Khurrana and Parineeti Chopra starrer 'Meri Pyari Bindu' tickled our funny bones, the fourth chapter has already made its way. Parineeti shared it on her Twitter handle by tweeting, "So easy to scandalise Abhi's MOM!!! Hahhahahaha here is Chapter 4 :) Bindu v/s Ma 😎😎😎 #MeriPyaariBindu." The chapter 4 shows Tom and Jerry equation between Bindu and Abhimanyu's mom. Bindu, who is Abhi's neighbour
AFEA Welcomes New Chapter President
Leader in Financial Literacy Continues to Expand The American Financial Education Alliance is dedicated to providing financial education and increasing financial literacy within communities all over the country. Today, the Board of Directors has chosen to continue to do just that, by unanimously voting in Robert Wolf as the new Chapter President of AFEA’s Orange, CA Chapter. With the addition of Robert Wolf as the new Chapter President, AFEA is expanding
AFEA Welcomes New Chapter President
The American Financial Education Alliance is dedicated to providing financial education and increasing financial literacy within communities all over the country. Today, the Board of Directors has chosen to continue to do just that, by unanimously voting in Anthony Cucchi as the new Chapter President of AFEA’s Newton Square, PA Chapter. With the addition of Anthony Cucchi as the new Chapter President, AFEA is expanding its geographical footprint to cover
AFEA Welcomes New Chapter President
Leader in Financial Literacy Continues to Expand The American Financial Education Alliance is dedicated to providing financial education and increasing financial literacy within communities all over the country. Today, the Board of Directors has chosen to continue to do just that, by unanimously voting in Angelica Jones as the new Chapter President of AFEA’s Glendale, California Chapter. With the addition of Angelica Jones as the new Chapter President, AFEA is expanding
SPS/GZ to Present at the Chapter Meeting of the Chicago Chapter of the NASPP
Chicago, IL, October 20, 2010 -- Stock Plan Solutions/Green Zapato LLC (SPS/GZ), a leader in equity compensation administration and outsourcing today announced that Rick Zatz, CEP, will be presenting at the meeting of the Chicago Chapter of the NASPP in October 27, 2010. The U.S. Treasury Department issued the final regulations relating to the return information statement requirements under IRC 6039. These regulations impose return and information statement reporting requirements on